On 29-30 January, 2013 forty experts in flu and other respiratory diseases came together to discuss the performance of Latin America’s surveillance and vaccination program surrounding influenza and other respiratory diseases. Attendees reviewed the available flu surveillance data from the Latin American region and debated the unanswered questions surrounding the knowledge gaps and possible methods to strengthen surveillance systems for both influenza and RSV. Special attention was also devoted to the available vaccines on the market today as well as those in varying stages of development by the ever expanding lot of producers.
The group also reviewed the limited surveillance data on other respiratory diseases such as respiratory syncytial virus (RSV), and in particular how the existing flu surveillance system can be tasked to gather data on RSV simultaneously. An overview of the clinical development pipeline of RSV vaccines showed a wide array of candidates at different stages of development. The group agreed, decision-makers will need much more data and thoughtful analysis in the coming decade to move forward with the implementation of an eventual RSV vaccine.
A more comprehensive report and next steps is under development.
To View the approved presentations from this event, please click here